Most people know about patches and gum. Fewer know that there are prescription medications for quitting smoking — no nicotine in them at all — with some of the strongest evidence in the entire field. This article explains the two main ones in plain language. It is not a prescription and not medical advice; it is the background reading that makes a five-minute doctor's appointment far more useful.
The first is varenicline, long sold under the brand name Champix or Chantix. It works on the same brain receptors nicotine does, and it does two clever things at once: it partially satisfies those receptors, which takes the edge off withdrawal and cravings, and it blocks them, which means that if you do smoke, the cigarette delivers noticeably less reward. People often describe cigarettes on varenicline as strangely pointless — and that dullness is the drug working. In head-to-head studies it is consistently among the most effective single quitting aids, roughly two to three times the quit rate of willpower alone. A typical course starts a week or so before your quit date and runs about twelve weeks. The best-known side effect is nausea, which is usually manageable and often settles; vivid dreams and sleep changes are also common. Earlier concerns about mood side effects led to years of extra scrutiny and a large dedicated trial; the alarming warnings were subsequently removed, but anyone with a significant mental health history should simply say so in the prescribing conversation.
The second is bupropion, sold for smoking cessation as Zyban and used elsewhere as an antidepressant. It works on different brain chemistry — the dopamine and noradrenaline systems that nicotine also touched — and it reliably beats placebo in quit trials, though it is generally a notch less effective than varenicline. It has two properties worth knowing about: it tends to blunt the appetite changes of early quitting, which matters to people worried about weight gain, and its antidepressant lineage can be a sensible fit when low mood is part of the picture. It is not for everyone — a history of seizures or eating disorders rules it out — which is exactly the kind of thing the prescribing conversation exists to check. Like varenicline, it starts one to two weeks before the quit date.
Three facts apply to both. They need a prescription and a short medical review, because the right choice depends on your history. They roughly double your odds rather than guaranteeing anything — the plan, the trigger work, and the support still matter. And they combine well with other tools: medication handles the chemistry while nicotine replacement, in some combinations, and human support handle the moments. Some of the best-performing approaches in the research pair a medication with exactly the kind of craving-moment support that no tablet provides.
One more thing worth saying plainly: using medication to quit is not cheating, any more than glasses are cheating at reading. Nicotine dependence is a physiological condition with effective treatments. Choosing one is not a weakness of character; it is a decision to use the full toolbox.
If any of this sounds like a fit, the next step is one unglamorous sentence at your next appointment: I want to quit smoking — can we talk about whether varenicline or bupropion makes sense for me? Doctors hear few sentences they like more.